Hint mode is switched on Switch off
For swift navigation between sections

Organization: Amgen
LEI 62QBXGPJ34PQ72Z12S66

Full name of organization
Amgen, Inc.
Country of risk
USA
Country of registration
USA
Industry
Healthсare
Credit ratings
in foreign currency
  • M/S&P/F
    ***/***/***
Bond debt
35,129 mln USD
DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS
  • High performance interface for global bond market screening
  • Full information on close to 400,000 bonds from 180 countries
  • 100% coverage of Eurobonds worldwide
  • Over 300 primary sources of prices
  • Ratings data from all international and local ratings agencies
  • Stock market data from 60 world trading floors
  • Intuitive, high speed user interface
  • Data access via the website, mobile application and add-in for Microsoft Excel

Latest data on

Profile

Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel
Amgen Inc. is an American multinational biopharmaceutical company headquartered in California. Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

Awards

Company analytics

{{ comment.date }}
All analytics

Latest issues

Documentation

Affiliates

Stocks

About company

Bond debt by currency

Codes

  • LEI
    62QBXGPJ34PQ72Z12S66
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • ICB
    4,500 Health Care
  • CIK
    0000318154

Credit ratings

Indices by country